How do triallists decide the two key features of a trial: which patients and what endpoints? And what is the future for SGLT2 inhibitors in…
Yet Another Blow To Combination Renin-Angiotensin-Aldosterone System Blockade
ACE inhibitors and angiotensin-receptor blockers have been found to effectively slow progression of kidney disease. It has been theorized that dual blockade of the renin-angiotensin-aldosterone system…